Amphstar Pharmaceuticals, Inc. Balance Sheet
AMPH / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
Amphstar Pharmaceuticals, Inc. had $1.6B in total assets and $789M in shareholders' equity as of FY2025. Total debt was $620M against $170M in cash, resulting in $450M net debt.
Based on SEC 10-K filings.
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $170.2M | $151.6M | $144.3M | $156.1M | $126.4M | $92.6M | $73.7M | $86.3M | $65.6M | $72.4M | $66.1M | $67.8M | $53.6M | $50.2M |
| Accounts Receivable | $143.6M | $136.3M | $114.9M | $88.8M | $78.8M | $66.0M | $45.4M | $52.2M | $36.0M | $26.8M | $33.2M | $22.9M | $24.6M | - |
| Inventory | $176.9M | $153.7M | $105.8M | $103.6M | $92.8M | $96.8M | $110.5M | $69.3M | $63.6M | $79.8M | $70.7M | $82.3M | $69.9M | - |
| Current Assets | $636.0M | $534.1M | $489.6M | $378.3M | $318.1M | $279.7M | $255.2M | $220.3M | $187.8M | $184.1M | $175.9M | $198.0M | $173.0M | - |
| PP&E (Net) | $310.6M | $297.3M | $282.7M | $238.3M | $244.2M | $260.1M | $233.9M | $210.4M | $180.5M | $152.9M | $142.2M | $138.3M | $116.6M | - |
| Goodwill | $3.4M | $3.0M | $3.2M | $3.1M | $3.3M | $3.9M | $3.6M | $4.0M | $4.5M | $4.0M | $3.7M | $4.5M | $280.0K | $280.0K |
| Total Assets | $1.6B | $1.6B | $1.5B | $742.0M | $671.5M | $631.2M | $587.0M | $513.6M | $451.1M | $427.7M | $390.1M | $389.4M | $338.7M | - |
| Current Liabilities | $158.2M | $173.8M | $225.4M | $94.9M | $103.8M | $112.2M | $90.0M | $106.8M | $67.2M | $60.6M | $60.0M | $62.6M | $65.4M | - |
| Total Debt | $619.7M | $613.5M | $603.2M | $76.6M | $78.2M | $45.9M | $46.3M | $49.1M | $45.7M | $36.0M | $40.3M | $42.7M | - | - |
| Shareholders' Equity | $788.8M | $732.3M | $639.4M | $528.7M | $445.5M | $402.3M | $381.4M | $332.4M | $333.7M | $329.3M | $295.5M | $281.9M | $251.5M | $233.4M |